CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity (Q83405571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Hidekazu Shirota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Dennis M Klinman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

4 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

659-669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

12 December 2020

Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs

1 reference

12 December 2020

Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.

1 reference

12 December 2020

Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model

1 reference

12 December 2020

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

12 December 2020

A Toll-like receptor recognizes bacterial DNA

1 reference

12 December 2020

Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.

1 reference

12 December 2020

Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells

1 reference

12 December 2020

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

1 reference

12 December 2020

Identification of tumour-associated T-cell epitopes for vaccine development

1 reference

12 December 2020

B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.

1 reference

12 December 2020

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

1 reference

12 December 2020

CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.

1 reference

12 December 2020

Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner

1 reference

12 December 2020

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

12 December 2020

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

12 December 2020

The promise of cancer vaccines

1 reference

12 December 2020

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice

1 reference

12 December 2020

Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity.

1 reference

12 December 2020

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

12 December 2020

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

12 December 2020

Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines

1 reference

12 December 2020

Immunotherapy and chemotherapy--a practical partnership

1 reference

12 December 2020

Vaccines for tumour prevention

1 reference

12 December 2020

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

1 reference

12 December 2020

Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma

1 reference

12 December 2020

Overview of tumor cell-based vaccines

1 reference

12 December 2020

Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells

1 reference

12 December 2020

Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs

1 reference

12 December 2020

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma

1 reference

12 December 2020

Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma

1 reference

12 December 2020

In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy

1 reference

12 December 2020

The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy

1 reference

12 December 2020

Immunogenic and tolerogenic cell death

1 reference

12 December 2020

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

1 reference

12 December 2020

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

12 December 2020

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.

1 reference

12 December 2020

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

1 reference

12 December 2020

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

12 December 2020

10.1007/S00262-011-0973-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21318638%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

21318638

1 reference